XWELL Price to Book Ratio 2010-2025 | XWEL
Historical price to book ratio values for XWELL (XWEL) over the last 10 years. The current price to book ratio for XWELL as of June 26, 2025 is 1.84.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| XWELL Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-27 | 0.94 | 1.73 | |
| 2025-03-31 | 1.02 | $0.54 | 1.88 |
| 2024-12-31 | 1.51 | $1.47 | 1.03 |
| 2024-09-30 | 1.73 | $2.82 | 0.61 |
| 2024-06-30 | 1.80 | $4.12 | 0.44 |
| 2024-03-31 | 1.69 | $4.49 | 0.38 |
| 2023-12-31 | 1.74 | $5.02 | 0.35 |
| 2023-09-30 | 2.25 | $6.53 | 0.34 |
| 2023-06-30 | 4.00 | $8.87 | 0.45 |
| 2023-03-31 | 7.20 | $10.22 | 0.70 |
| 2022-12-31 | 7.20 | $11.52 | 0.62 |
| 2022-09-30 | 15.40 | $14.78 | 1.04 |
| 2022-06-30 | 13.80 | $16.77 | 0.82 |
| 2022-03-31 | 22.60 | $18.47 | 1.22 |
| 2021-12-31 | 40.40 | $19.74 | 2.05 |
| 2021-09-30 | 29.40 | $19.73 | 1.49 |
| 2021-06-30 | 30.80 | $17.75 | 1.73 |
| 2021-03-31 | 36.80 | $18.60 | 1.98 |
| 2020-12-31 | 23.80 | $17.09 | 1.39 |
| 2020-09-30 | 39.40 | $16.90 | 2.33 |
| 2020-06-30 | 83.80 | $10.50 | 7.98 |
| 2020-03-31 | 11.40 | $-4.02 | -2.84 |
| 2019-12-31 | 40.20 | $-9.84 | -4.09 |
| 2019-09-30 | 86.40 | $93.30 | 0.93 |
| 2019-06-30 | 116.40 | $212.74 | 0.55 |
| 2019-03-31 | 144.00 | $340.84 | 0.42 |
| 2018-12-31 | 192.00 | $447.32 | 0.43 |
| 2018-09-30 | 180.00 | $592.35 | 0.30 |
| 2018-06-30 | 348.00 | $797.22 | 0.44 |
| 2018-03-31 | 864.00 | $991.99 | 0.87 |
| 2017-12-31 | 1644.00 | $2,072.81 | 0.79 |
| 2017-09-30 | 1668.00 | $2,524.77 | 0.66 |
| 2017-06-30 | 1980.00 | $3,266.38 | 0.61 |
| 2017-03-31 | 2604.00 | $3,771.83 | 0.69 |
| 2016-12-31 | 2556.00 | $4,207.07 | 0.61 |
| 2016-09-30 | 3228.00 | $2,029.80 | 1.59 |
| 2016-06-30 | 2268.00 | $2,375.46 | 0.95 |
| 2016-03-31 | 1968.00 | $3,203.20 | 0.61 |
| 2015-12-31 | 2964.00 | $3,678.07 | 0.81 |
| 2015-09-30 | 6720.00 | $1,811.89 | 3.71 |
| 2015-06-30 | 6720.00 | $2,551.16 | 2.63 |
| 2015-03-31 | 7800.00 | $3,366.89 | 2.32 |
| 2014-12-31 | 6600.00 | $4,006.40 | 1.65 |
| 2014-09-30 | 11400.00 | $13,513.86 | 0.84 |
| 2014-06-30 | 41040.00 | $14,804.84 | 2.77 |
| 2014-03-31 | 41640.00 | $15,258.88 | 2.73 |
| 2013-12-31 | 35520.00 | $16,230.44 | 2.19 |
| 2013-09-30 | 34440.00 | $18,559.41 | 1.86 |
| 2013-06-30 | 38040.00 | $19,630.45 | 1.94 |
| 2013-03-31 | 38040.00 | $20,318.57 | 1.87 |
| 2012-12-31 | 34440.00 | $21,738.72 | 1.58 |
| 2012-09-30 | 34800.00 | $16,686.31 | 2.09 |
| 2012-06-30 | 46320.00 | $-0.09 | -507894.74 |
| 2012-03-31 | 19800.00 | $0.07 | 268656.72 |
| 2011-12-31 | 11880.00 | $0.28 | 43184.30 |
| 2011-09-30 | 17040.00 | $-0.55 | -30919.98 |
| 2011-06-30 | 14640.00 | $-0.29 | -49762.07 |
| 2011-03-31 | 20400.00 | $-0.16 | -126472.41 |
| 2010-12-31 | 28560.00 | $-0.04 | -644695.26 |
| 2010-09-30 | 39600.00 | $0.01 | 2657718.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| CVS Health (CVS) | United States | $86.198B | 10.71 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| ICON (ICLR) | Ireland | $11.851B | 11.02 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| HealthEquity (HQY) | United States | $9.068B | 39.72 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| Organon (OGN) | United States | $2.594B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| LifeMD (LFMD) | United States | $0.615B | 0.00 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |